Forbes Highlights How Krystyna Houser and mBIOTA Labs Revolutionized the Elemental Diet

In a recent feature by Forbes, Krystyna Houser, founder of mBIOTA Labs, shared her journey in transforming the elemental diet (ED) into a palatable, effective solution for individuals managing gastrointestinal (GI) disorders. mBIOTA Elemental™ represents a breakthrough in medical nutrition, overcoming long-standing barriers of poor taste and compliance while maintaining clinical efficacy for conditions like Small Intestinal Bacterial Overgrowth (SIBO).

The Drive Behind Innovation
Houser’s personal experience battling GI disorders, including SIBO, fueled her determination to create a better elemental diet. Historically, EDs have been a proven treatment for GI disorders, but adherence rates were low due to their unpalatable taste. “The diet worked, but it made a hard situation even harder,” Houser shared. Teaming up with Dr. Mark Pimentel and Dr. Ali Rezaie from Cedars-Sinai, Houser embarked on an eight-year journey to develop mBIOTA Elemental™. Leveraging cutting-edge taste technology, the team created a proprietary formula that solved the amino acid taste barrier, making EDs tolerable and effective.

Clinical Results and Impact
Clinical trials conducted at Cedars-Sinai showcased mBIOTA Elemental™’s groundbreaking results:

• 100% Patient Adherence: Unprecedented compliance during the two-week trial.
• 83% SIBO Eradication: Far surpassing the 50% success rate of standard antibiotics.
• Significant Symptom Improvement: Up to 65% reduction in 12 common GI symptoms.
• Body Composition Benefits: A mean body fat reduction of 11.2% after four weeks, with sustained results post-diet.

These results highlight the potential of mBIOTA Elemental™ not only in managing GI conditions but also in supporting weight management and reducing visceral fat.

Expanding Applications
Houser and her team are exploring additional applications for the elemental diet, including its use in:

• Gut resets for improved GI function.
• Supplemental nutrition for patients on GLP-1 treatments for weight loss.
• Conditions like eosinophilic esophagitis, chronic pancreatitis, celiac disease, and rheumatoid arthritis.

Looking Ahead
As mBIOTA Elemental™ gains traction among doctors and practitioners, Houser envisions a broader impact. “We’re excited to move into other areas of health and wellness based on what we’ve learned,” she said. With ongoing clinical trials and a mission to redefine GI health management, mBIOTA Labs is setting new standards in functional nutrition.

To read the full article, click here.